Voloshko P - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Loxapine delivered as a thermally generated aerosol does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Spyker DA, Voloshko P, Heyman ER, Cassella JV. Spyker DA, et al. Among authors: voloshko p. J Clin Pharmacol. 2014 Jun;54(6):665-74. doi: 10.1002/jcph.257. Epub 2014 Jan 22. J Clin Pharmacol. 2014. PMID: 24375070 Clinical Trial.

Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.

Kori S, Kellerman DJ, Voloshko P, Haugen G. Kori S, et al. Among authors: voloshko p. Clin Ther. 2012 Sep;34(9):1920-8. doi: 10.1016/j.clinthera.2012.08.001. Epub 2012 Aug 21. Clin Ther. 2012. PMID: 22917853 Clinical Trial.

The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety.

Seltzer J, Senatore F, Faulkner K, Stein KM, Browning LS, Voloshko P, Papadopoulos EJ. Seltzer J, et al. Among authors: voloshko p. Am Heart J. 2022 Jan;243:122-126. doi: 10.1016/j.ahj.2021.09.005. Epub 2021 Sep 20. Am Heart J. 2022. PMID: 34555331 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters